Results 111 to 120 of about 6,242 (166)

Type I IFN-controlled Qa-2 expression identifies and maps the generation of Eomes⁺ thymic innate CD8 T cells. [PDF]

iScience
Won HY, Joo MK, Lanasa D, Hong C, Park JH.   +4 more
europepmc   +1 more source

How experimental models have unlocked hidden mechanisms of hypersensitivity pneumonitis. [PDF]

Eur Respir Rev
Cabrera S, Pardo A, Selman M.
europepmc   +1 more source

Safety of ozanimod and etrasimod in ulcerative colitis: A disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System database. [PDF]

Medicine (Baltimore)
Chen L, Wan D, Xing B, Ji X, Zhou W, Liu Y, Lu Y.   +6 more
europepmc   +1 more source

The S1P/S1P1 Signaling Axis Plays Regulatory Functions in the Crosstalk Between Brain-Metastasizing Melanoma Cells and Microglia. [PDF]

Cancers (Basel)
Adir O, Sagi-Assif O, Ben-Menachem S, Witz IP, Izraely S.   +4 more
europepmc   +1 more source

Repurposing the SSRI paroxetine increases lymphocyte mobilization and improves the efficacy of measles virus-based immunovirotherapy. [PDF]

Mol Ther Oncol
Stergiopoulos GM, Concilio SC, Viker KB, Clark SM, Robinson SI, Galanis E.   +5 more
europepmc   +1 more source

Tyrosine Sulphation of Sphingosine 1-Phosphate 1 (S1P1) is Required for S1P-mediated Cell Migration in Primary Cultures of Human Umbilical Vein Endothelial Cells

Sphingosine 1-phosphate (S1P), a lysophospholipid mediator, regulates diverse functions of many types of cells by binding to specific G protein-coupled receptors termed S1P1\u96S1P5.
-
core  

The Impact of Multiband and In-Plane Acceleration on White Matter Microstructure Analysis. [PDF]

Hum Brain Mapp
Zhang Z, Venkataraman A, Cole M, Ye T, Qiu D, Lin FV, Risk BB.   +6 more
europepmc   +1 more source

Fibroblast growth factors in ischemic stroke: Therapeutic potential and clinical challenges. [PDF]

Acta Pharmacol Sin
Dordoe C, Guo KM, Bwalya C, Huang WT, Chen SH, Chen J, Wang X, Wang P, Li XK, Li L.   +9 more
europepmc   +1 more source

Extracellular Vesicle-Associated miRNA in Multiple Sclerosis Subtypes: Differential Profiles in Secondary Progressive Disease and the Effect of One-Year Siponimod Treatment. [PDF]

Cells
Vrînceanu O, Maier S, Manu D, Bănescu C, Bălașa R.   +4 more
europepmc   +1 more source

Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic Approach. [PDF]

Neurol Int
Martinisi A, Paganetti P.
europepmc   +1 more source